Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

New oral agent shows promise in treatment of relapsed multiple myeloma

A new agent that subverts myeloma cells from within while also subjecting them to an immune system attack produced impressive responses in combination with dexamethasone in patients with multiple myeloma that had relapsed and stopped responding to all currently available therapies, a clinical trial conducted by researchers at Dana-Farber Cancer Institute and around the world has found.

30 Aug 2023

Bio-Rad enhances flow cytometry capabilities for veterinary immunology research with new StarBright Dyes

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range with 29 additional highly validated antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 Dyes.

From Bio-Rad Laboratories 30 Aug 2023

West Nile virus surges to highest incidence since 2012

Researchers discuss the surveillance of West Nile virus and other arboviruses in the United States.

29 Aug 2023

Light-driven bacteria could be used to target and kill cancer cells

Targeting malignant tumors with high precision is challenging for biomedical researchers. However, this scenario is likely to witness a paradigm shift in the near future, through the use of specially engineered bacteria, that can eliminate malignant cells efficiently.

29 Aug 2023

Study finds that germline-encoded specificities cannot always predict the trajectory of B-cell responses

Researchers used computational simulations and experiments to investigate how genetic variations encoded in the germline impact B-cell responses.

29 Aug 2023

New optical signature in magnetic beads could quickly detect contaminants in diagnostic tests

Getting results from a blood test can take anywhere from one day to a week, depending on what a test is targeting. The same goes for tests of water pollution and food contamination.

25 Aug 2023

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.

25 Aug 2023

UTMB research potentially points to an effective treatment for Lassa fever

New research out of the University of Texas Medical Branch potentially points to an effective treatment for Lassa fever, a dangerous, often fatal disease common to much of West Africa but considered a major threat to global health.

24 Aug 2023

Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Researchers investigated whether anti‑interleukin 6 monoclonal antibodies were related to heterogenous treatment effects between male and female COVID-19 patients.

24 Aug 2023

Timing and cost of new vaccines vary by virus and health insurance status

As summer edges toward fall, thoughts turn to, well, vaccines.

24 Aug 2023

Study shows that CD98hc can be targeted to deliver biotherapeutics in brain

Researchers engineered and characterized a blood-brain barrier transport vehicle targeting the CD98 heavy chain of heterodimeric amino acid transporters.

24 Aug 2023

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, extended survival for patients with advanced gastric or gastroesophageal junction cancer that overexpressed a specific biomarker.

23 Aug 2023

People with compromised immune systems less likely to have COVID-19 antibodies, study finds

New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.

23 Aug 2023

New kidney tissue model could help assess safety of immunotherapy drugs

A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells.

23 Aug 2023

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.

From Rapid Novor Inc 23 Aug 2023

Project NextGen awards over $1.4 billion to develop the future of COVID-19 vaccines and therapeutics

Funding includes $1 billion for vaccine clinical trials, $326 million for a new monoclonal antibody, and $100 million to explore novel vaccine and therapeutic technologies.

23 Aug 2023

Current and future strategies for vaccinating against invasive pneumococcal disease

Researchers reviewed the immune mechanisms employed by existing vaccines for invasive pneumococcal disease.

23 Aug 2023

New microneedles could monitor melanoma therapy response

Patients with melanoma, the most concerning form of skin cancer in which pigment-producing cells start to grow out of control, can benefit from existing immunotherapies, but by far not all of them do.

21 Aug 2023

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

COVID-19 can increase the risk of various autoimmune diseases; however, this risk appears to be mitigated by vaccination against COVID-19.

21 Aug 2023

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

A hybrid approach involving a combination of conventional discovery and antibody repurposing to combat COVID-19.

21 Aug 2023

Antibody News and Research

Further Reading

New oral agent shows promise in treatment of relapsed multiple myeloma

Bio-Rad enhances flow cytometry capabilities for veterinary immunology research with new StarBright Dyes

West Nile virus surges to highest incidence since 2012

Light-driven bacteria could be used to target and kill cancer cells

Study finds that germline-encoded specificities cannot always predict the trajectory of B-cell responses

New optical signature in magnetic beads could quickly detect contaminants in diagnostic tests

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

UTMB research potentially points to an effective treatment for Lassa fever

Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Timing and cost of new vaccines vary by virus and health insurance status

Study shows that CD98hc can be targeted to deliver biotherapeutics in brain

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

People with compromised immune systems less likely to have COVID-19 antibodies, study finds

New kidney tissue model could help assess safety of immunotherapy drugs

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

Project NextGen awards over $1.4 billion to develop the future of COVID-19 vaccines and therapeutics

Current and future strategies for vaccinating against invasive pneumococcal disease

New microneedles could monitor melanoma therapy response

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

eBook: End-to-end solutions for bispecific antibody development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo